Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

ClinicalTrials.gov ID: NCT04892706

Public ClinicalTrials.gov record NCT04892706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel (0.3% Adapalene/2.5% BPO), in the Treatment of Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The safety and efficacy of once daily application of IDP 126 Gel will be compared to Epiduo® Forte and IDP-126 Vehicle Gel.

Study identification

NCT ID
NCT04892706
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
686 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 99 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2021 (Actual)
Primary completion
Sep 28, 2022 (Actual)
Completion
Sep 28, 2022 (Actual)
Last update posted
Oct 30, 2025

2021 – 2022

United States locations

U.S. sites
34
U.S. states
19
U.S. cities
30
Facility City State ZIP Site status
Bausch Site 134 Bryant Arkansas 72022 —
Bausch Site 118 Rogers Arkansas 72758 —
Bausch Site 110 Fremont California 94538 —
Bausch Site 101 Manhattan Beach California 90266 —
Bausch Site 106 San Diego California 92123 —
Bausch Site 112 San Diego California 92123 —
Bausch Site 128 San Diego California 92123 —
Bausch Site 105 Boynton Beach Florida 33437 —
Bausch Site 126 Clearwater Florida 33761 —
Bausch Site 135 North Miami Beach Florida 33162 —
Bausch Site 143 Sanford Florida 32771 —
Bausch Site 102 Tampa Florida 33607 —
Bausch Site 104 West Palm Beach Florida 33401 —
Bausch Site 122 West Palm Beach Florida 33406 —
Bausch Site 124 Newnan Georgia 30263 —
Bausch Site 127 Boise Idaho 83704 —
Bausch Site 129 Louisville Kentucky 40241 —
Bausch Site 139 Mandeville Louisiana 70448 —
Bausch Site 121 Metairie Louisiana 70006 —
Bausch Site 116 Rockville Maryland 20850 —
Bausch Site 103 Brighton Massachusetts 21350 —
Bausch Site 120 New Brighton Minnesota 55112 —
Bausch Site 108 Las Vegas Nevada 89148 —
Bausch Site 119 New York New York 10022 —
Bausch Site 133 New York New York 10075 —
Bausch Site 142 High Point North Carolina 27262 —
Bausch Site 109 Dublin Ohio 43016 —
Bausch Site 117 Oklahoma City Oklahoma 73112 —
Bausch Site 107 Gresham Oregon 97030 —
Bausch Site 114 Nashville Tennessee 37215 —
Bausch Site 111 Austin Texas 78759 —
Bausch Site 132 Houston Texas 77098 —
Bausch Site 123 Pflugerville Texas 78660 —
Bausch Site 137 Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04892706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04892706 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →